Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ROSUVASTATIN CALCIUM USP, with a corresponding US DMF Number 28888.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 19, 2015, and payment made on January 13, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II